FEDERALhearing transcript

Congressional Hearing: The Impact of the Opioid Epidemic on American Workplaces

Original title: THE OPIOIDS EPIDEMIC: IMPLICATIONS FOR AMERICA'S WORKPLACES

January 1, 2018

opioid epidemic workplace safety public health labor policy employment law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing serves as a formal record of expert testimony and legislative inquiry into how the opioid epidemic impacts workforce productivity and employer legal obligations, which informs future federal labor and health policy.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Employers

Employers face challenges regarding workplace safety, productivity, and legal compliance related to employees affected by opioid use.

Employees

Workers may be impacted by workplace policies, safety standards, and health support systems related to the opioid crisis.

What changed

Last recorded activity January 1, 2018.

What's next

Next step not available in the current record.

Summary

This document is a transcript of a joint Congressional hearing held on February 15, 2018, by the House Committee on Education and the Workforce. Lawmakers and expert witnesses discussed how the opioid crisis affects labor participation, workplace safety, and employer responsibilities.

Key Facts

The hearing took place on February 15, 2018, in the Rayburn House Office Building.
The session was a joint hearing between the Subcommittee on Health, Employment, Labor, and Pensions and the Subcommittee on Workforce Protections.
The hearing focused on the intersection of the opioid epidemic and American workplace dynamics.
Four expert witnesses provided testimony: Lisa Allen, Dr. Christina M. Andrews, Corwin Rhyan, and Kathryn J. Russo.
The proceedings were recorded as Serial No. 115-35 of the 115th Congress.

Why It Matters

Frequently Asked Questions

What was the purpose of this hearing?

The hearing was held to examine the implications of the opioid epidemic on the American workforce and to gather expert testimony on the subject.

Who participated in the hearing?

The hearing was conducted by the House on Health, Employment, Labor, and Pensions and the Subcommittee on Workforce Protections, featuring testimony from health analysts, legal experts, and business leaders.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift80% confidence

Focus on Workplace Impact

The hearing highlights a shift in legislative focus toward the economic and workplace-specific consequences of the opioid crisis rather than just clinical or law enforcement aspects.

House Committee on Education and the Workforce

Connected Entities

personTim Walberg“Chairman of the Subcommittee on Health, Employment, Labor, and Pensions”Map →

personCorwin Rhyan“Senior Health Care Analyst at Altarum Institute, witness”Map →

personBradley Byrne“Chairman of the Subcommittee on Workforce Protections”Map →

personDr. Christina M. Andrews“Assistant Professor at the University of South Carolina, witness”Map →

organizationHouse Committee on Education and the Workforce“Congressional committee overseeing the hearing”Map →

personLisa Allen“President and CEO of Ziegenfelder Company, witness”Map →

personKathryn J. Russo“Principal at Jackson Lewis P.C., witness”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance60
How much this matters to a regular citizen
Controversy20
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz10
Current news / social attention level

Publisher tools